Individual synthetic, sequence-verified quantified positive controls targeting the hemagglutinin (HA) gene, neuraminidase (NA) gene, and matrix (M) gene of Influenza A H5N1 -- critical regions for virus detection and subtyping. Precisely quantified and calibrated to defined copy numbers, these controls are designed to support accurate detection, assay calibration, and quantitative performance assessment in molecular assays. They enable robust assay validation, sensitivity and limit-of-detection (LoD) evaluation, and verification of amplification efficiency and assay linearity. Compatible with real-time PCR and other nucleic acid amplification platforms, the controls ensure reliable monitoring of assay performance, primer and probe specificity, and inter-run comparability. Suitable for research, assay development, and routine quality control workflows, these controls provide reproducible and dependable detection for surveillance, diagnostic, and epidemiological applications (RUO)